Comparision of the efficacy and safety between Secukinumab and Adalimumab in the treat-ment of the moderate to severe plaque psoriasis
HU Dandan
ZHANG Peimiao
Machine-generated Keywords：
Publication Date：2023-06-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 246-252 )